What is Hepaglide 1.7 mg Injection

Hepaglide 1.7 mg Injection is used for weight management in individuals with Obesity and related conditions such as heart disease. Its active ingredient is FDA-approved Semaglutide base (1.7 mg), a Glucagon-like Peptide-1 (GLP-1) receptor agonist. Alkem Laboratories Ltd manufactures it under strict GMP standards.

Semaglutide mimics a natural hormone (GLP-1) that helps regulate hunger, slows down digestion, and controls blood sugar levels. This medication is primarily used for long-term weight management in patients aged 12 and above who are obese or overweight-related conditions. It is also used for treating Nonalcoholic Steatohepatitis (NASH) with moderate to advanced liver scarring.

Hepaglide 1.7 mg should be administered subcutaneously once weekly, along with a healthy diet and exercise. The medication is injected using a multi-dose disposable pen with provided needles and swabs.

In case of an overdose, seek immediate medical help. If you miss a dose, take it as soon as possible within 5 days, then resume your regular weekly schedule. If more than 5 days have passed, skip the dose and take the next one on the scheduled day.

Common side effects of this injection are nausea, vomiting, diarrhea, stomach pain, constipation, and headaches, which usually improve over time. Seek medical attention if you experience severe abdominal pain or allergic reactions.

Avoid alcohol, as it can cause blood sugar fluctuations and worsen side effects. Always inform your doctor of any other medications or conditions, such as thyroid problems, to avoid potential interactions.

Store Hepaglide injection in the refrigerator at 2-8°C and do not freeze. After the first use, you can keep it at a room temperature (below 30°C) for up to 56 days, away from light.

What are the benefits of taking Hepaglide 1.7 mg Injection

Hepaglide 1.7 mg Injection provides several key benefits, particularly in weight management and cardiovascular health, due to its active ingredient, Semaglutide base. They are:

• It minimizes appetite, promotes a feeling of fullness, and curbs cravings, making it easier to follow a reduced-calorie diet.
• It lowers the chances of heart attack, stroke, or cardiovascular death in adults with Obesity and heart disease. It also helps improve blood pressure, cholesterol levels, and markers of inflammation.
• Hepaglide helps enhance blood sugar control and maintain glycemic stability. It also supports liver health, especially in conditions like Nonalcoholic Steatohepatitis (NASH).

Additionally, Hepaglide is administered using a convenient, multi-dose disposable pen. The pen allows for easy and precise self-injection once a week. The pen comes with pre-filled doses, making it simple for users to dial in the appropriate dose.

How to use Hepaglide 1.7 mg Injection

Hepaglide 1.7 mg Injection is a prescription medicine and should be used strictly as prescribed by your doctor. Here are the general guidelines for proper use:

• Inject it once a week on the same day each week, at any convenient time.
• Do not self-administer unless trained by a doctor or a nurse. They will determine the injection route and dosage plan.
• It can be used with or without food, but following a fixed weekly schedule helps improve consistency.
• Do not use it more often than prescribed.

Strengths and Substitutes

As of now, only 1 strength of Hepaglide is available at Cheap Medicine Shop. However, you can find effective substitutes with the same active ingredient to suit your medical requirements. Always consult a doctor before opting for them.

View all substitutes

What are the side effects of Hepaglide 1.7 mg Injection

Hepaglide 1.7 mg Injection is generally well tolerated, but you may experience some mild side effects as your body adjusts to the medication. These usually improve over time.

• Nausea or vomiting
• Diarrhea or constipation
• Abdominal pain or bloating
• Headache
• Injection site reactions (redness, swelling, or irritation)
• Fatigue or dizziness

However, if they continue or worsen, consult your doctor immediately.

Safety Advice

Liver Disease

There is limited data on its use in patients with liver disease. Inform your doctor about any liver issues, as it may cause elevated liver enzymes or other health concerns.

Kidney Impairment

Use Hepaglide 1.7 mg Injection with caution in patients with kidney disease, as it may worsen kidney function or exacerbate dehydration-related issues, such as vomiting. Close monitoring is necessary if you have kidney impairment.

Pregnant and Breastfeeding women

Hepaglide is not safe during pregnancy, as it may cause congenital disabilities or pregnancy loss. Discontinue at least 2 months before planning pregnancy. It is also not recommended during breastfeeding, as it may harm the baby.

Avoid

Avoid using Hepaglide 1.7 mg Injection if you have a history of Medullary Thyroid Carcinoma, Multiple Endocrine Neoplasia Type 2, Pancreatitis, or a known hypersensitivity to Semaglutide. Avoid alcohol as it can worsen nausea, vomiting, dehydration, and low blood sugar risk while using this medicine, especially with Insulin or Sulfonylureas. Avoid driving or operating machinery if weakness, shakiness, confusion, or lightheadedness occurs.